The firm has raised $78 million to date and is launching its first clinical trial to test a treatment for ...

The European Commission on Monday approved AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) as a tissue-agnostic treatment for previously treated patients with unresectable or ...

The firm also said it completed enrollment in the Phase III 4FRONT-2 clinical trial of 4D-150 in wet AMD ahead of schedule.

The company is planning to test its oral immunotherapy in over 800 patients with resectable and unresectable tumors.

The firm will use the proceeds to advance its pipeline of RNA medicines, like AX-0810 and AX-0811, and its Axiomer RNA-editing platform.

The CAR-T maker will finance a second year of grants, educational resources, and surveying for patients and caregivers.

Saturnus uses targeted gene modulation to address rare monogenetic cardiomyopathies with significant unmet need.

In a clinical trial, Redemplo led to a median 80 percent decrease in fasting triglyceride levels from baseline.

The positive decision is based on results from a Phase III study evaluating first-line Datroway against chemotherapy.

During its research day, the firm discussed a cell therapy effort in lupus, dubbed "007," and an AI platform for gleaning ...

The firms will explore the combination of VS-7375 and ERAS-0015 in KRAS G12D-mutant solid tumor models before moving to clinical studies.

Taysha Gene Therapies on Wednesday proposed a $200 million underwritten public offering of its stock and prefunded warrants, which will support development of its gene therapy for Rett syndrome.